Price
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
Below averageCONMED is a medical technology company that provides devices and equipment for surgical procedures. The Company’s products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. The Company’s 3,900 employees distribute its products worldwide from three primary manufacturing locations.
In the company’s own words · 10-K filed Feb 17, 2026 · SEC EDGAR
Business segments
Jun 2026 · $152.3MThe company’s own SEC segment disclosure.
- United States$51.7M34%
- EMEA$40.3M26%
- Asia Pacific$36.6M24%
- Americasexcludingthe United States$23.8M16%
CONMED Corporation (CNMD) reported revenue of $373M in Q4 2025 (quarter ended Dec 31, 2025), up 7.9% from the same quarter a year earlier. That came with a gross margin of 58% and net income of $17M (4.5% of revenue). For the full year FY2025, revenue was $1.37B (+5.2% year on year) and net income $47M. Its largest region in Jun 2026 was United States at $52M, 34% of the disclosed total, ahead of EMEA at 26%.
Raw charts
11 series · TTMAs reported to the SEC, without any scoring.